A new study published in The Lancet reveals that fewer than one in five women in low- and middle-income countries receive early cancer diagnoses, significantly impacting survival rates.
- The research, conducted by the London School of Hygiene and Tropical Medicine, analyzed over 275,000 womens data between 2015 and 2018 across 39 countries, highlighting disparities in cervical cancer and ovarian cancer detection.
- In developing countries, fewer than 20% of women are diagnosed with breast or cervical cancer at an early stage, compared to higher rates in wealthier nations, exacerbating mortality risks.
- The Lancet study emphasizes the urgent need for improved healthcare access and early diagnosis to enhance survival rates for women facing cancer in low-income areas.
Why It Matters
This study underscores a critical health disparity affecting women in low-income regions, stressing the need for global health initiatives aimed at improving early cancer detection and treatment access, which can save lives.